Marked successes in treating a wide variety of malignancies in both adults and children have raised concerns about the cardiotoxic sequelae of several mainstream and emerging cancer therapies.
Opportunities to Meet Clinical Cardio-Oncology Needs With New Approaches to Non-Clinical Safety Assessment.
Progress in Pediatric Cardiology, 2014